Zimmer Biomet Holdings Inc. Stock Rises 3.4%, Outperforms Market
Dow Jones2026/10/12 20:35This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Zimmer Biomet Holdings Inc. rallied 3.4% to $92.17 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.4% to 51,850.55 and the S&P 500 Index falling 0.1% to 7,807.24.
This was the stock's third consecutive day of gains.
Zimmer Biomet Holdings Inc. closed 13.8% below its 52-week high of $106.88, which the company reached on October 22nd.
The stock demonstrated a mixed performance when compared to some of its peers, as Johnson & Johnson rose 0.9% to $263.73, Medtronic PLC rose 3.9% to $91.93, and Stryker Corp. rose 1.90% to $282.60.
Trading volume totaled 1.8 million, compared to the 50-day average of 2.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 12, 2026 16:35 ET (20:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
USD/JPY Price Forecast: Hits one week low as bears eye trading range support near 157.50
Susquehanna raises pre-earnings price targets for chip stocks: AMD (AMD.US), Qualcomm (QCOM.US), etc. receive upward revisions
Susquehanna has adjusted the target prices for chip stocks such as AMD, Intel, and Qualcomm.
Wedbush: Hard drive supply falls short of demand, Seagate (STX.US) and Western Digital (WDC.US) earnings reports may bring surprises
Wedbush reiterated its "outperform" ratings for Seagate and Western Digital, setting target prices at $1,000 and $650, respectively.
JPMorgan maintains Underweight rating on Nike (NKE.US): Deep in adjustment pains, performance pressures may persist until fiscal year 2028
Recently, JPMorgan released a U.S. equity research report on Nike. The research team participated in a face-to-face meeting with Nike's new CFO, Denton, updated profit assumptions based on management statements, and maintained an “underweight” investment rating on Nike.
Crypto prices
More
